NFKB1 and leukemia: The biological activity of artepillin C has been reported to reduce the inflammatory response by inhibiting NFκB on macrophages (Szliszka et al., 2013), to increase cytotoxic activity on natural killer cells (Takeda et al., 2018) to inhibit the release of cys‐leukotrienes from the HL‐60 leukemia cell line (Tani et al., 2010).